| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/18/2005 | EP1530573A1 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 05/18/2005 | EP1530572A2 Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents |
| 05/18/2005 | EP1530568A1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING I&kB KINASE |
| 05/18/2005 | EP1530567A1 Pyridinyl substituted (1,2,3,)triazoles as inhibitors of the tgf-beta signalling pathway |
| 05/18/2005 | EP1530566A1 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them |
| 05/18/2005 | EP1530565A1 Substituted thiophene carboxamide compounds for the treatment of inflammation |
| 05/18/2005 | EP1530494A1 A pharmaceutical preparation containing palladium complex compounds and the uses thereof for treating cancer and autoimmune disease |
| 05/18/2005 | EP1530482A1 Use of urease for inhibiting cancer cell growth |
| 05/18/2005 | EP1530478A2 Exemestane for first-line treatment of breast cancer |
| 05/18/2005 | EP1530476A1 Use of reboxetine for the treatment of hot flashes |
| 05/18/2005 | EP1530474A1 Enhancing the effect of radioimmunotherapy in the treatment of tumors |
| 05/18/2005 | EP1530473A2 Regulation of erythrocyte apoptosis |
| 05/18/2005 | EP1530465A1 Method of producing a cationic liposomal preparation comprising a lipophilic compound |
| 05/18/2005 | EP1530459A2 Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment |
| 05/18/2005 | EP1392290B1 Use of certain substituted pyrrolidones such as piracetam in the treatment of viral and other diseases |
| 05/18/2005 | EP1301184B1 Valproic acid and derivatives thereof as histone deacetylase inhibitors |
| 05/18/2005 | EP1265860B1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 05/18/2005 | EP1263724B1 Novel compounds |
| 05/18/2005 | EP1261367B1 Use of interleukin-6 antagonists for the treatment of oestrogen dependent tumours |
| 05/18/2005 | EP1233787B8 Product inhibiting transduction of g heterotrimeric protein signals combined with another anti-cancer agent for therapeutic use in cancer treatment |
| 05/18/2005 | EP1145011B1 Compositions and methods for the diagnosis and treatment of tumor |
| 05/18/2005 | EP1098885B9 Imidazole compounds and their use as adenosine deaminase inhibitors |
| 05/18/2005 | EP1076652B1 N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate |
| 05/18/2005 | EP1034185B1 Pharmaceutical compositions containing the long pentraxin ptx3 |
| 05/18/2005 | EP0970187B1 Pituitary differentiation factor and methods of use thereof |
| 05/18/2005 | EP0839055B1 Modified methioninase, its use, recombinant host cells producing high levels of methioninase and method for purifying methioninase |
| 05/18/2005 | EP0820461B1 Aryl-ester phosphoramidate derivatives of 2',3'-didehydronucleosides |
| 05/18/2005 | EP0662137B1 Gene transcription and ionizing radiation: methods and compositions |
| 05/18/2005 | CN1617928A Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers |
| 05/18/2005 | CN1617922A Composition of antibody specifically binding to CD20 |
| 05/18/2005 | CN1617888A Bispecific antibody DNA constructs for intramuscular administration |
| 05/18/2005 | CN1617884A Beta-amyloid binding factors and inhibitors thereof |
| 05/18/2005 | CN1617883A Solid salts of benzazepine compounds and pharmaceutical compositions containing them |
| 05/18/2005 | CN1617879A 17alpha-alkyl-17beta-oxy-estratrienes and intermediates for the production thereof, and use of said 17alpha-alkyl-17beta-oxy-estratrienes for producing medicaments and pharmaceutical preparations |
| 05/18/2005 | CN1617877A Use of phosphonate nucleotide analogue for treating hepatitis b virus infections |
| 05/18/2005 | CN1617874A Hexacyclic compounds |
| 05/18/2005 | CN1617870A N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl) -n-phenylamines as antiproliferative compounds |
| 05/18/2005 | CN1617864A Thiadiazoline derivative |
| 05/18/2005 | CN1617859A 5-sulfanyl-4h-1, 2, 4-triazole derivatives and their use as a medicament |
| 05/18/2005 | CN1617858A Pyrimidine derivatives as modulators of insulin-like growth factor-1 receptor (igf-1) |
| 05/18/2005 | CN1617856A Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them |
| 05/18/2005 | CN1617755A Fpt inhibitor and use of other anti-tumor agent in combination in preparing anticancer drug |
| 05/18/2005 | CN1617744A Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors |
| 05/18/2005 | CN1617732A Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 05/18/2005 | CN1617725A Tyrosyl derivatives and their use as P2X7 receptor modulators |
| 05/18/2005 | CN1617724A Neurotransmitter balance chemotherapy |
| 05/18/2005 | CN1617721A Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and use thereof |
| 05/18/2005 | CN1617715A Treating muscle wasting with selective androgen receptor modulators |
| 05/18/2005 | CN1617713A Ultrapure oral fludara formulation with a fast releasing active substance |
| 05/18/2005 | CN1617711A Liposomal delivery of vitamin E based compounds |
| 05/18/2005 | CN1617710A Liposome composition for delivery of nucleic acid |
| 05/18/2005 | CN1616671A Natural antitumor or antiviral substances and use of the same |
| 05/18/2005 | CN1616665A Targeted liposome gene delivery |
| 05/18/2005 | CN1616661A Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors |
| 05/18/2005 | CN1616488A Primary structure of Anjikang protein of snake soure desintegration mutant anti-tumor medicine |
| 05/18/2005 | CN1616487A Liver cancer apoptosis inducing factor and its encoding gene and use |
| 05/18/2005 | CN1616484A Novel cyclopeptide anti-tumor, anti-virus antibiotic active compound |
| 05/18/2005 | CN1616476A Small interference ribonucleic acid molecule for epidermal growth facor gene and its use |
| 05/18/2005 | CN1616452A 维生素d类似物 Vitamin d analogues |
| 05/18/2005 | CN1616444A Unsaturated lactone compound and its preparing method and use |
| 05/18/2005 | CN1616430A Rosinyl acridine its producing method and use thereof |
| 05/18/2005 | CN1616428A Acenaphthene heterocyclic compound and its cell fading inducing and anti-tumor use |
| 05/18/2005 | CN1616424A Novel ceramide compound with cell fading inducing activity and its preparing method |
| 05/18/2005 | CN1616386A Intermediate for preparing isothiazole derivatives |
| 05/18/2005 | CN1616109A Method for MG 7-Ag analogue epitope to construct stomack cancer specific poly epitope gene vaccine |
| 05/18/2005 | CN1616107A Gene engineering recombined vaccine of carcinoma of cervix uterus |
| 05/18/2005 | CN1616099A Anti-cancer medicine composition |
| 05/18/2005 | CN1616098A Anti-cancer medicine composition |
| 05/18/2005 | CN1616082A Use of compound methionine enkephalin as medicine for treating brain cancer, kidney cancer and liver cancer |
| 05/18/2005 | CN1616077A Chinese medicine compound preparation for treating lung cancer |
| 05/18/2005 | CN1616074A Glossy ganoderma spore oil fat emulsion |
| 05/18/2005 | CN1616055A Medicinal composition containing Aerican ginseng and tuber of dwarf lily turf effective part and its preparing method |
| 05/18/2005 | CN1616039A Sichuan aconite root freeze-dried powder injection and its preparing method |
| 05/18/2005 | CN1616034A Granular preparation for treating cancer and its quality control method |
| 05/18/2005 | CN1616030A Use of compound preparation in treating human hepatitis, cancer, diabetes and uremia |
| 05/18/2005 | CN1615970A Chinese medicine preparation compound Huangdai tablet for treating leukemia and its jpreparing method |
| 05/18/2005 | CN1615966A Cancer pain killing combined Chiese medicine |
| 05/18/2005 | CN1615955A Auxiliary medicine for anti-tumor and its preparing method |
| 05/18/2005 | CN1615917A Concurrent medicine for cancer in late stage or chemotherapy |
| 05/18/2005 | CN1615907A Carbon gas gel transfusion agent, its preparing method and its use |
| 05/18/2005 | CN1615905A White arsenic local slow release chemical therapeutic medicine for treating malignant brain tumor |
| 05/18/2005 | CN1615904A Process for preparing white arsenic nano particles |
| 05/18/2005 | CN1615901A medicine composition containing protopanoxadiol and its preparing method |
| 05/18/2005 | CN1615884A Use of lycopene in producing medicine |
| 05/18/2005 | CN1615873A Azaindoles compound |
| 05/18/2005 | CN1615865A Cepharanthine dripping pill and preparing process |
| 05/18/2005 | CN1615855A Temozolomide-polymer local slow release chemotherapy medicine for treating malignant brain tumor |
| 05/18/2005 | CN1615852A Indirubin oral dripping pill and preparing process |
| 05/18/2005 | CN1615845A Unit dosage type norcantharidine acid or its derivative powder injection and its preparing method |
| 05/18/2005 | CN1615841A Taxinol-sodium alginate micro ball vascular embolism agent and its preparation |
| 05/18/2005 | CN1615836A Rubidate soft capsule and its preparing method |
| 05/18/2005 | CN1615833A N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 05/18/2005 | CN1615828A Garlicin injection emulsion and its preparing method |
| 05/18/2005 | CN1202135C Chi Iucid ganoderma polysaccharide and prep. and use thereof |
| 05/18/2005 | CN1202134C Polysaccharide compound having immune stimulating activity |
| 05/18/2005 | CN1202127C Immunostimulant bacterial membrane tractions in cancer treatment |
| 05/18/2005 | CN1202114C Oxalibo purification |
| 05/18/2005 | CN1202104C 2-phenylpyran-4-one derivatives |
| 05/18/2005 | CN1202096C 2-aminothiazoline derivatives and their use as no-synthase inhibitors |
| 05/18/2005 | CN1202093C Substituted heterocyclic compound |